Literature DB >> 23832936

Understanding chemical reactivity for homo- and heterobifunctional protein cross-linking agents.

Fan Chen1, Simone Nielsen, Renato Zenobi.   

Abstract

Chemical cross-linking, combined with mass spectrometry, has been applied to map three-dimensional protein structures and protein-protein interactions. Proper choice of the cross-linking agent, including its reactive groups and spacer arm length, is of great importance. However, studies to understand the details of reactivity of the chemical cross-linkers with proteins are quite sparse. In this study, we investigated chemical cross-linking from the aspects of the protein structures and the cross-linking reagents involved, by using two structurally well-known proteins, glyceraldehyde 3-phosohate dehydrogenase and ribonuclease S. Chemical cross-linking reactivity was compared using a series of homo- and hetero-bifunctional cross-linkers, including bis(sulfosuccinimidyl) suberate, dissuccinimidyl suberate, bis(succinimidyl) penta (ethylene glycol), bis(succinimidyl) nona (ethylene glycol), m-maleimidobenzoyl-N-hydroxysulfosuccinimide ester, 2-pyridyldithiol-tetraoxaoctatriacontane-N-hydrosuccinimide and succinimidyl-[(N-maleimidopropionamido)-tetracosaethyleneglycol]ester. The protein structure itself, especially the distances between target amino acid residues, was found to be a determining factor for the cross-linking efficiency. Moreover, the reactive groups of the chemical cross-linker also play an important role; a higher cross-linking reaction efficiency was found for maleimides compared to 2-pyrimidyldithiols. The reaction between maleimides and sulfhydryl groups is more favorable than that between N-hydroxysuccinimide esters and amine groups, although cysteine residues are less abundant in proteins compared to lysine residues.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  2-pyridyldithiol; MALDI mass spectrometry; N-hydroxysuccinimide (NHS) esters; amine-to-sulfhydryl cross-links; chemical cross-linking; maleimides

Mesh:

Substances:

Year:  2013        PMID: 23832936     DOI: 10.1002/jms.3224

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  11 in total

Review 1.  Mass spectrometry in studies of protein thiol chemistry and signaling: opportunities and caveats.

Authors:  Nelmi O Devarie Baez; Julie A Reisz; Cristina M Furdui
Journal:  Free Radic Biol Med       Date:  2014-09-28       Impact factor: 7.376

2.  Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.

Authors:  Rashmi Jalah; Oscar B Torres; Alexander V Mayorov; Fuying Li; Joshua F G Antoline; Arthur E Jacobson; Kenner C Rice; Jeffrey R Deschamps; Zoltan Beck; Carl R Alving; Gary R Matyas
Journal:  Bioconjug Chem       Date:  2015-06-05       Impact factor: 4.774

3.  On the efficiency of NHS ester cross-linkers for stabilizing integral membrane protein complexes.

Authors:  Fan Chen; Sabina Gerber; Volodymyr M Korkhov; Samantha Mireku; Monika Bucher; Kaspar P Locher; Renato Zenobi
Journal:  J Am Soc Mass Spectrom       Date:  2014-11-18       Impact factor: 3.109

4.  DFT study of the mechanisms of nonenzymatic DNA repair by phytophenolic antioxidants.

Authors:  Meriem Zerrouki; Farid Benkaci-Ali
Journal:  J Mol Model       Date:  2018-03-02       Impact factor: 1.810

Review 5.  Chemical cross-linking with mass spectrometry: a tool for systems structural biology.

Authors:  Juan D Chavez; James E Bruce
Journal:  Curr Opin Chem Biol       Date:  2018-08-30       Impact factor: 8.822

6.  Characterization and optimization of heroin hapten-BSA conjugates: method development for the synthesis of reproducible hapten-based vaccines.

Authors:  Oscar B Torres; Rashmi Jalah; Kenner C Rice; Fuying Li; Joshua F G Antoline; Malliga R Iyer; Arthur E Jacobson; Mohamed Nazim Boutaghou; Carl R Alving; Gary R Matyas
Journal:  Anal Bioanal Chem       Date:  2014-08-02       Impact factor: 4.142

7.  Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins.

Authors:  Federico Baruffaldi; April Huseby Kelcher; Megan Laudenbach; Valeria Gradinati; Ajinkya Limkar; Michaela Roslawski; Angela Birnbaum; Andrew Lees; Carla Hassler; Scott Runyon; Marco Pravetoni
Journal:  Mol Pharm       Date:  2018-10-10       Impact factor: 4.939

8.  Construction and characterization of a truncated tissue factor‑coagulation‑based composite system for selective thrombosis in tumor blood vessels.

Authors:  Peilan Xu; Mingyuan Zou; Shengyu Wang; Tingting Li; Cong Liu; Li Wang; Lanlan Wang; Fanghong Luo; Ting Wu; Jianghua Yan
Journal:  Int J Oncol       Date:  2019-08-12       Impact factor: 5.650

9.  In Situ Structural Restraints from Cross-Linking Mass Spectrometry in Human Mitochondria.

Authors:  Petra S J Ryl; Michael Bohlke-Schneider; Swantje Lenz; Lutz Fischer; Lisa Budzinski; Marchel Stuiver; Marta M L Mendes; Ludwig Sinn; Francis J O'Reilly; Juri Rappsilber
Journal:  J Proteome Res       Date:  2019-12-19       Impact factor: 4.466

10.  Complementary Benzophenone Cross-Linking/Mass Spectrometry Photochemistry.

Authors:  Adam Belsom; Gemma Mudd; Sven Giese; Manfred Auer; Juri Rappsilber
Journal:  Anal Chem       Date:  2017-05-04       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.